Navigation Links
American Regent Initiates Voluntary Recall of Magnesium Sulfate Injection, USP 50% (25 grams/50 mL), 50mL Single Dose Vial Lot # 0491
Date:11/5/2010

SHIRLEY, N.Y., Nov. 5, 2010 /PRNewswire/ -- American Regent is conducting a nationwide voluntary recall of:

Magnesium Sulfate Injection, USP 50% (25 grams/50mL) 50 mL Single Dose Vial NDC # 0517-2650-25, Lot # 0491, Exp. Date: 8/2012

PLEASE NOTE: This recall, initiated on October 29, 2010 to the User Level, is for Lot # 0491 Only.  No other lots of Magnesium Sulfate Injection, USP are subject of this recall.

This voluntary recall was initiated because some vials of this lot were observed to be slightly discolored and upon standing have the appearance of sediment on the bottom of the vials.  American Regent is undertaking this recall in consideration of the potential for safety issues if this lot of product is administered to patients.

The product was distributed to wholesalers and distributors nationwide.

Hospitals, infusion centers, clinics and other healthcare facilities should not use American Regent Inc., Magnesium Sulfate Injection, USP, Lot# 0491, for patient care and should immediately quarantine any product for return.

"Patient safety is our primary concern, and we are committed to taking the necessary steps to protect patients from any potential safety risks," said Mary Jane Helenek, President and CEO of American Regent.

While American Regent continues to investigate this issue, the company is taking precautionary action and initiated this voluntary recall.  American Regent has informed the FDA of its actions and is maintaining ongoing discussions with the agency.

As is standard practice, and as stated in the Magnesium Sulfate Injection, USP Product Package Insert, "Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit."

American Regent will credit accounts for all returned Magnesium Sulfate Injection, USP product with Lot # 0491. Those with questions about the return process, please call our Customer Service Department at 1-800-645-1706: Monday thru Friday from 8:30 AM to 7:00 PM ET.

Hospitals, infusion centers, clinics and healthcare providers, or patients with other questions may contact the Professional Services Department at 631-924-4000.

Any adverse reactions experienced with the use of this product, and/or quality problems should be reported to American Regent, Inc. via email at PV@luitpold.com, by fax to 610-650-7781 or 610-650-0170 or by phone at 1-800-734-9236. Adverse reactions may also be reported to FDA's MedWatch Adverse Event Reporting program online, or by returning the postage paid FDA form 3500, by mail to [MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787] or via fax [1-800-FDA-0178] or phone 1-800-332-1088.

Magnesium Sulfate Injection, USP is manufactured by Luitpold Pharmaceuticals, Inc. and is distributed by American Regent, Inc. (Shirley, NY).

About Luitpold Pharmaceuticals, Inc.

Luitpold Pharmaceuticals, Inc., headquartered in Shirley, NY, manufactures and distributes over 80 pharmaceutical products including Venofer® (iron sucrose injection, USP), the leading IV iron therapy in the U.S., through its human health subsidiary, American Regent, Inc. Luitpold Pharmaceuticals, Inc., a Daiichi Sankyo group company, also markets dental bone regeneration products and veterinary pharmaceuticals through its Osteohealth and Animal Health divisions. Daiichi Sankyo Company, Ltd., established in 2005 after the merger of two leading century-old Japanese pharmaceutical companies, is a global pharmaceutical innovator, continuously generating innovative drugs that enrich the quality of life for patients around the world.


'/>"/>
SOURCE Luitpold Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation
2. United American Healthcare Corporation Announces Senior Management Appointments and Relocation to Chicago
3. Americans Use Hand Sanitizers for Peace of Mind but Dont Know Leading Hand Sanitizers Stop Working After Two Minutes
4. Shire Presents Positive New Data at the 60th Annual American Society of Human Genetics (ASHG) for Patients with Type 1 Gaucher Disease
5. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
6. American Oriental Bioengineering to Announce Third Quarter 2010 Financial Results on November 9, 2010
7. Accurays CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting
8. Universal American Announces New Medicare Part D Benefit Making LIPITOR® and CRESTOR® Available for Low or No Copay(1)
9. Veteran Pharmaceutical Executives Form New American Therapeutics, Inc.
10. Over 20 New Clinical Studies Presented on Masimo Noninvasive Patient Monitoring Technologies at the American Society of Anesthesiologists Annual Meeting
11. Hospitalizations for Medication and Illicit Drug-related Conditions on the Rise Among Americans Ages 45 and Older
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... India , February 22, 2017 ... Radio Synthesis Modules Market: Global Opportunity Analysis and Industry Forecast, ... worth $20 million in 2015 and projected to reach $32 ... 2016 to 2022. North America accounted ... and unit volumes, whereas Asia-Pacific region ...
(Date:2/22/2017)... A research report by Arcview Market Research focused on cannabis ... changing landscape of the legal market reveals that regulated cannabis sales ... , a 30% increase from 2015. According to the research ... 2021 representing a 26 percent compound annual growth rate. The use ... Canada is gradually becoming more mainstream thanks ...
(Date:2/22/2017)... Feb 22, 2017 Research and Markets has ... & Trends - Industry Forecast to 2025" report to their offering. ... The Global Clot Management ... over the next decade to reach approximately $2.1 billion by 2025. ... for all the given segments on global as well as regional levels ...
Breaking Medicine Technology:
(Date:2/22/2017)... , ... February 22, 2017 , ... ANGLESTRONG , ... Angle, is now available on the App Store and Google Play ... apps for the addiction and recovery industry, partnered with Angle to build ANGLESTRONG. The ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... ProGen™ PRP, the latest innovation in the delivery of Platelet Rich Plasma (PRP). ... cardiovascular and pain management, to accelerate tissue synthesis and provide a faster and ...
(Date:2/22/2017)... Staefa, Switzerland (PRWEB) , ... February 22, 2017 ... ... have difficulty hearing and 72 percent of those report that family members or ... those who think they suffer from hearing loss wear hearing aids. One reason, ...
(Date:2/22/2017)... North Carolina (PRWEB) , ... February 22, 2017 , ... ... of cats and 54% of dogs, according to the Association for Pet Obesity Prevention ... disagreed on key pet food issues such as the benefits of corn and grains, ...
(Date:2/22/2017)... ... ... BrightStar Care Charleston , a home care and medical staffing agency, will ... on Aging’s Senior Expo on Thursday, March 23, 2017, at the Omar Convention ... our community. We are thrilled to participate in this event because we believe it ...
Breaking Medicine News(10 mins):